Wenkel H, Rummelt V, Naumann G O
Department of Ophthalmology, University of Erlangen-Nürnberg, Erlangen, Germany.
Br J Ophthalmol. 2000 Mar;84(3):279-84. doi: 10.1136/bjo.84.3.279.
Severe mucus deficiency syndromes may require substitution of mucous membrane for re-establishment of the ocular surfaces. The long term results after autologous nasal mucosal transplantation were investigated.
55 eyes of 50 patients with severe mucus deficiency syndromes were followed retrospectively after free autologous nasal mucosal transplantation-group A: patients after severe lye, acid, heat burns, or radiation (n=38 eyes), group B: patients with systemic mucosal disease (n=17 eyes). The results of routine clinical examination were recorded and patients were followed for a median of 37 months. 17 biopsies of transplanted nasal mucosa were studied by light microscopy and 22 patients by impression cytology before and at several intervals after mucosal transplantation.
All nasal mucosal grafts healed well and no intraoperative complications occurred. During follow up 107 additional surgical procedures were performed including 16 lamellar and 21 penetrating keratoplasties. Subjective complaints improved in 44/47 patients with preoperative symptoms. Best corrected visual acuity at the end of follow up was increased in 23 eyes, 10 eyes (18. 2%) reached a final visual acuity equal to or greater than 20/200. Histopathologically, all (n=17) biopsies showed vital intraepithelial mucin producing goblet cells in the nasal mucosal graft (median 25 cells/field (400x magnification)). The mean density of goblet cells before transplantation was 48/mm(2) and after nasal mucosal grafting 432/mm(2) measured by impression cytology (p<0. 0001).
Functional goblet cells persist in autologous nasal mucosa for up to 10 years after transplantation. In patients with severe mucus deficiency syndromes of different origin nasal mucosal transplantation can re-establish the ocular surface, substitute the mucus components of the tear film, improve symptoms of the patients, and facilitate a moderate increase in visual acuity.
严重黏液缺乏综合征可能需要替代黏膜以重建眼表。研究自体鼻黏膜移植后的长期效果。
对50例严重黏液缺乏综合征患者的55只眼进行回顾性研究,这些患者接受了自体游离鼻黏膜移植。A组:严重碱液、酸液、热烧伤或辐射伤患者(38只眼);B组:患有全身性黏膜疾病的患者(17只眼)。记录常规临床检查结果,并对患者进行中位时间为37个月的随访。对17例移植鼻黏膜活检组织进行光镜检查,对22例患者在黏膜移植前及移植后不同时间间隔进行印片细胞学检查。
所有鼻黏膜移植物愈合良好,术中无并发症发生。随访期间共进行了107次额外的手术,包括16次板层角膜移植和21次穿透性角膜移植。44/47例术前有症状的患者主观症状得到改善。随访结束时,23只眼的最佳矫正视力提高,10只眼(18.2%)最终视力达到或超过20/200。组织病理学检查显示,所有17例活检标本的鼻黏膜移植物中均可见有活力的上皮内产生黏蛋白的杯状细胞(中位值为每视野25个细胞(400倍放大))。通过印片细胞学检查,移植前杯状细胞的平均密度为48/mm²,鼻黏膜移植后为432/mm²
(p<0.0001)。
移植后功能性杯状细胞在自体鼻黏膜中可持续存在长达10年。对于不同病因的严重黏液缺乏综合征患者,鼻黏膜移植可重建眼表,替代泪膜中的黏液成分,改善患者症状,并使视力适度提高。